TW201612520A - Tumor examination composition and test paper for tumor examination - Google Patents

Tumor examination composition and test paper for tumor examination

Info

Publication number
TW201612520A
TW201612520A TW104132865A TW104132865A TW201612520A TW 201612520 A TW201612520 A TW 201612520A TW 104132865 A TW104132865 A TW 104132865A TW 104132865 A TW104132865 A TW 104132865A TW 201612520 A TW201612520 A TW 201612520A
Authority
TW
Taiwan
Prior art keywords
tumor examination
examination
composition
tumor
test paper
Prior art date
Application number
TW104132865A
Other languages
Chinese (zh)
Other versions
TWI551862B (en
Inventor
Setsuro Yamada
Original Assignee
Setsuro Yamada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Setsuro Yamada filed Critical Setsuro Yamada
Publication of TW201612520A publication Critical patent/TW201612520A/en
Application granted granted Critical
Publication of TWI551862B publication Critical patent/TWI551862B/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

An objective of this invention is to provide a novel malignant tumor examination method, which is unlike a blood test that usually causes harm to the human body, the method is an presureless and easy and convenient for the person under examination, and has a relatively low false positive possibility. In this invention relates to a composition for tumor examination that contains aromatic aldehydes, or cinnamic aldehydes in particular, and a test paper for tumor examination obtained by drying a filter paper added with the composition for tumor examination.
TW104132865A 2014-10-31 2015-10-06 Tumor examination composition and test paper for tumor examination TWI551862B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014223288A JP5796863B1 (en) 2014-10-31 2014-10-31 Tumor examination composition and tumor examination test paper

Publications (2)

Publication Number Publication Date
TW201612520A true TW201612520A (en) 2016-04-01
TWI551862B TWI551862B (en) 2016-10-01

Family

ID=54348584

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104132865A TWI551862B (en) 2014-10-31 2015-10-06 Tumor examination composition and test paper for tumor examination

Country Status (4)

Country Link
JP (1) JP5796863B1 (en)
CN (1) CN105572109B (en)
HK (1) HK1224014A1 (en)
TW (1) TWI551862B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109507408B (en) * 2018-11-01 2019-10-11 陶海南 A kind of tumor screening composition and its test paper
CN111413393A (en) * 2019-12-20 2020-07-14 杭州师范大学 Method for rapidly detecting formaldehyde content in food by high-throughput reaction paper spray mass spectrometry

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010053833A1 (en) * 2008-11-04 2010-05-14 Vymedic, Llc Antiviral supplement formulations
EP2438445B1 (en) * 2009-06-04 2014-07-16 Metanomics Health GmbH Methods for diagnosing prostate carcinomas
EP2301368A1 (en) * 2009-09-08 2011-03-30 Mars, Incorporated Composition for prevention against spoilage by microorganisms and uses and products related thereto
KR101370613B1 (en) * 2012-01-31 2014-03-26 주식회사 디에프아이 Means for detecting reactive oxygen species in human

Also Published As

Publication number Publication date
JP2016090335A (en) 2016-05-23
JP5796863B1 (en) 2015-10-21
CN105572109A (en) 2016-05-11
CN105572109B (en) 2017-09-22
HK1224014A1 (en) 2017-08-11
TWI551862B (en) 2016-10-01

Similar Documents

Publication Publication Date Title
JOP20200192A1 (en) Anti-tigit antibodies
NZ731467A (en) Anti-tim3 antibodies and methods of use
MY173162A (en) Immune balance regulator
EP4060048A3 (en) Non-invasive diagnostic method for diagnosing bladder cancer
MX2016002423A (en) Diagnostic methods and compositions for treatment of glioblastoma.
EA201692100A8 (en) NEW ANTIBODIES AGAINST RNF43 AND METHODS OF THEIR APPLICATION
EP4321866A3 (en) Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers
MX2015007185A (en) Use of eribulin in the treatment of breast cancer.
EA201691952A1 (en) COMPOSITIONS AND METHODS RELEVANT TO DIAGNOSTIC PROSTATE CANCER
MX2020002216A (en) Methods and compositions for detecting and treating endometriosis.
WO2014205266A3 (en) Compositions and methods for detecting and treating glioblastoma
PH12019500725A1 (en) Methods of treating acute kidney injury
WO2014200969A3 (en) Methods of treatment of cancer
MA40636A (en) Methods of detecting prostate cancer
TW201612520A (en) Tumor examination composition and test paper for tumor examination
EP3549582A3 (en) Novel capsazepine analogs for the treatment of cancer and other proliferative diseases
EA201892562A1 (en) METHODS AND MATERIALS FOR DETERMINING STAGES AND TREATING SKIN CANCER
EA201790609A1 (en) MACRO CYCLIC INHIBITORS RIP2-KINASE
WO2015013233A3 (en) Methods and compositions for the treatment and diagnosis of bladder cancer
WO2016046759A3 (en) Compositions and methods for treating friedreich's ataxia
MX2016010948A (en) Compositions and methods for identifying b cell malignancies responsive to b cell depleting therapy.
MX2018003313A (en) Modified natural killer cells having anti-fugetactic properties and uses thereof.
WO2017011559A8 (en) Compositions and methods for treating cancer
EP4328245A3 (en) Antibodies for use in treating conditions related to specific pcsk9 variants in specific patients populations
MX2018003317A (en) Modified t-cells having anti-fugetactic properties and uses thereof.

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees